Pelthos Therapeutics Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Pelthos Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $57.71. The average 1-year stock price forecast is 106.03% higher than the current stock price, while the lowest is $48 (+71.37%) and the highest is $75 (+167.76%).

Price Target: $57.71 (+106.03%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$48	$57.71	$55	$75
Change	+71.37%	+106.03%	+96.36%	+167.76%

Analyst Ratings

The average analyst rating for Pelthos Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	5	5	5	6	6	6
Buy	0	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	6	6	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
James Molloy Alliance Global Partners	Alliance Global Partners	Buy Reiterates $75	Buy	Reiterates	$75	+167.76%	Jun 15, 2026
Jonathan Aschoff Roth MKM	Roth MKM	Buy Maintains $55	Buy	Maintains	$55	+96.36%	May 15, 2026
Ben Haynor Lake Street	Lake Street	Buy Maintains $50	Buy	Maintains	$50	+78.51%	May 15, 2026
Jeff Jones Oppenheimer	Oppenheimer	Buy Reiterates $62 → $66	Buy	Reiterates	$62 → $66	+135.63%	May 15, 2026
Brandon Folkes H.C. Wainwright	H.C. Wainwright	Buy Reiterates $60	Buy	Reiterates	$60	+114.21%	May 15, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

63.92M

from 16.80M

280.56%

from 16.80M

Revenue Next Year

121.18M

from 63.92M

89.59%

from 63.92M

EPS This Year

-10.66

from -13.29

EPS Next Year

-2.13

from -10.66

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	16.80M	63.92M
Revenue Growth	-	-	-	-	-	280.56%
Gross Profit	-209.05K	-391.73K	-	-1.18M	11.58M	52.14M
Gross Margin	-	-	-	-	68.94%	81.58%
Operating Income	-839.00K	-2.32M	-6.86M	-7.57M	-31.41M	-38.54M
Net Income	-595.39K	-2.46M	-7.38M	-7.96M	-43.32M	-41.39M
EPS	-	-	-	-	-13.29	-10.66
Free Cash Flow	-	-	-640.57K	-6.96M	-24.65M	-11.00M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	79.5M
Avg	63.9M
Low	56.4M

Revenue Growth

Revenue Growth	2026	2027	2028
High	373.5%
Avg	280.6%
Low	235.8%

EPS Forecast

EPS	2026	2027	2028
High	-6.88
Avg	-10.66
Low	-16.43

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-